Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Vedanta says net-zero transition investments top US$ 1 billion over five years

Vedanta says net-zero transition investments top US$ 1 billion over five years

ReutersReuters2026/08/20 09:26
  • Vedanta invested more than USD 1 billion in net-zero transition initiatives over the past five years.
  • Renewable energy use rose 52% year over year to 4 billion units in FY2025-26.
  • Installed and contracted renewable capacity reached nearly 2,000 MW; target set at 2.5 GW of round-the-clock renewables by 2030.
  • Decarbonisation actions avoided about 36 million tonnes of CO2e since FY2021; emissions intensity fell about 14% from the FY2020-21 baseline.
  • Vedanta Oil & Gas secured OGMP 2.0 Gold Standard Pathway status for methane reporting, described as the first for an Indian upstream peer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vedanta Limited published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)

A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.

智通财经2026/08/29 02:27
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)